Four things to know:
1. Net sales were $2 billion, and full-year sales for 2024 grew 3.8% year over year with $7.7 billion.
2. Knee sales in the fourth quarter grew 5.1% year over year with $839.2 million, and hip sales grew 3% to $520 million.
3. Fourth quarter sports medicine, extremities, trauma, craniomaxillofacial and thoracic sales grew 8% year over year to $489 million.
4. Zimmer Biomet expects 2025 sales to increase 1% to 3.5% year over year.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
